Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer
Conditions
- Head and Neck Cancer
- Squamous Cell Cancer
Interventions
- DRUG: Imatinib Mesylate
- DRUG: Docetaxel
Sponsor
M.D. Anderson Cancer Center
Collaborators